A remarkable 22% of patients had new monogenic disease risks, previously unknown to them or higher than expected. instead of showing signs of nervousness and upset, the patients took the next step into seeing a physician to discuss what they could do about it.
Integrating genome sequencing and other omics technologies into the day-to-day practice of medicine is an extraordinarily exciting prospect with the potential to anticipate and prevent diseases throughout an individual’s lifetime,” said senior author Robert C. Green, MD, MPH.
The idea of finding a risk in their beautiful baby of something that might or might not happen is terrifying or repugnant,” he says. “But other types of people are information seekers.”
Green was quite up front about for a man who directs a sequencing project (Harvard and Brigham and Women’s Genomes2People program), was dramatic: “Is genomic information toxic?” he pondered. “Is the information itself bad for you?”
Dr. Robert Green discusses genetic privacy concerns and questions about whole genome sequencing that have arisen from parents whose children are participating in the BabySeq project.
“Les parents, grands curieux, seraient même fous des données génomiques!”